PAA

0.00%

17.5¢ pharmaust limited

I'm not sure it's just about the sample size.BP have paid...

First 54 Last

Share
Profile

Follow
FloatingCity

632 Posts.

107

01/08/24

12:45

Post #: 75025412
Share

Originally posted by 21391401: ↑

I agree no buyout imminent.

I also identify with the “what am I missing” doubts.

As highlighted before, sample size too small and big pharma risk averse, because the BP employee is risking the firms capital and not their own, so they are more interested in downside protection and getting it right, where as us investors have an eye to the upside potential and are prepared to absorb more risk. They will/ may lose their job at the end of the day, if they get it wrong. So all in all, I don’t think much action from BP soon.

However, the market is full of many other investors, why don’t they recognise the risk reward payoff that we do.

Whilst the ALS average survival times are close to 2 years, this hides a very wide range, Daniher & Stephen Hawking are 2 examples used by MT who prove my point, they lived with it for years. Hence I think the market sees that you should be ultra careful in extrapolating our P1 and OLE data.

What I don’t think is well understood here, is that although the OLE and P1 trial was a very small sample size, the matching that Berry have done for us, should control for that very wind range of deterioration rates (not absolutely, but for the most part). Berry is a very reputable organisation and aren’t risking their reputation to slightly fudge the numbers for an ASX minnow.

Hence the continuation of the OLE, will help with the unwind of the discount rate being applied to PAA (higher share price), so patience is the order of the day! Our risk is lower, and our potential is much higher, than the market is crediting us with.

Expand

I'm not sure it's just about the sample size.

BP have paid billions for promising pre-clinical drugs in the neurodegenerative space.

I wonder how much PAA being an ASX listed company impacts on BP's interesting in acquisitions.

PAA Price at posting: 19.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

CBA breaks trading record on strong day for Aussie financials

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

As Nvidia cools, we're looking to Aussie AI

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

There are more pages in this discussion • 15 more messages in this thread...

First 54 Last

Add PAA (ASX) to my watchlist

(20min delay)
Last 17.5¢		Change 0.000(0.00%)		Mkt cap ! $85.12M

Open	High	Low	Value	Volume
18.0¢	18.0¢	17.0¢	$141.2K	801.7K

Buyers (Bids)

No.	Vol.	Price($)
11	537419	17.0¢

Sellers (Offers)

Price($)	Vol.	No.
18.0¢	140000	3

View Market Depth

No.	Vol.	Price($)
11	537419	0.170
5	157060	0.165
9	476304	0.160
6	336734	0.155
8	225333	0.150

Price($)	Vol.	No.
0.180	140000	3
0.185	427553	5
0.190	720215	6
0.195	752882	12
0.200	297726	10

Last trade - 16.10pm 06/09/2024 (20 minute delay)

PAA (ASX) Chart

I'm not sure it's just about the sample size.BP have paid...

CBA breaks trading record on strong day for Aussie financials

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

As Nvidia cools, we're looking to Aussie AI

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Red Mountain Mining: record gold prices, two projects, two greenstone belts

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Shekel Brainweigh investor presentation webinar – the future of retail automation

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I'm not sure it's just about the sample size.BP have paid...

Top Stories

CBA breaks trading record on strong day for Aussie financials

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

As Nvidia cools, we're looking to Aussie AI

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Red Mountain Mining: record gold prices, two projects, two greenstone belts

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Shekel Brainweigh investor presentation webinar – the future of retail automation

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News